Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TLR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COL27A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAND2P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MYCNOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EWSAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP6R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTYMK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F30P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on